
LINK . SPRINGER . COM {
}
Title:
Cyclooxygenase (COX)-2 immunoreactivity and relationship to p53 and Ki-67 expression in colorectal cancer | Journal of Gastroenterology
Description:
The tumor-suppressive effects of nonsteroidal antiinflammatory drugs (NSAIDs) have been suggested to be due to a reduction in cyclooxygenase (COX)-2 activity, although the effects of COX-2 in the colonic mucosa and in colorectal cancer have not been determined. Ki-67 immunoreactivity in cancers is also attracting attention, as Ki-67 reflects cell proliferation, while p53 immunoreactivity is also of interest, as it reflects the malignancy of colorectal lesions. Accordingly, to determine these correlation, we investigated the distribution and intensity of COX-2, p53 and Ki-67 expression in both cancerous and non-cancerous tissues from patients with sporadic and ulcerative colitis (UC)-associated colorectal cancer. We selected 21 colorectal cancer specimens, obtained by surgical resection or colonoscopic biopsy, from 21 patients, including 3 with UC (13 men and 8 women; aged 42β78 years). Histological examination of hematoxylin and eosin-stained specimens revealed that 9 were well differentiated; 11, moderately differentiated; and 1 was a poorly differentiated adenocarcinoma. We used anti-COX-2, p53, and Ki-67 antisera to perform immunohistochemical staining by the labelled streptavidin biotin method and then assessed and graded the staining intensity and distribution. COX-2 staining was more intense in cancer tissue than in non-cancerous areas. Colorectal cancers associated with UC were not stained intensely. COX-2, p53, and Ki-67 positivity rates in were 38.1%, 38.1%, and 47.6%, respectively. There were no relationships among the distributions or intensities of COX-2, p53, and Ki-67 expression. Our results indicate that colorectal cancer tissues overexpress COX-2, but that there are no relationships between COX-2, p53, and Ki-67 expression, suggesting that COX-2 expression may not be related to cell proliferation or to the grade of malignancy. However, it is necessary to determine whether COX-2 in cancer tissue is involved in carcinogenesis or whether it is simply a product of cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {π}
- Health & Fitness
- Education
- Social Networks
Content Management System {π}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {π}
What is the average monthly size of link.springer.com audience?
π Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,734,772 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {πΈ}
We're unsure if the website is profiting.
Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.
Keywords {π}
cancer, cox, colorectal, article, access, expression, privacy, cookies, content, journal, information, publish, search, immunoreactivity, open, data, log, research, cyclooxygenase, sakuma, fujimori, hirabayashi, differentiated, staining, related, discover, medicine, springer, optional, analysis, personal, including, parties, policy, find, track, gastroenterology, relationship, march, cite, kazuhiro, takahiro, kaoru, akira, terano, explore, effects, suggested, cancers, reflects,
Topics {βοΈ}
ulcerative colitis month download article/chapter eosin-stained specimens revealed colorectal cancer published colorectal cancer screening privacy choices/manage cookies full article pdf colorectal cancer related subjects european economic area nonsteroidal antiinflammatory drugs independent prognostic factor disease-free survival dokkyo university school ki-67 positivity rates conditions privacy policy article sakuma cancer tissue perform immunohistochemical staining check access instant access accepting optional cookies tumor-suppressive effects poorly differentiated adenocarcinoma takahiro fujimori journal finder publish usage analysis march 1999 volumeΒ 34 article journal article log cancer information colorectal lesions cell proliferation article cite privacy policy personal data colorectal cancers books a cancerous tissues optional cookies manage preferences stained intensely hirabayashi journal publish subscription content similar content ki-67 expression ki-67 antisera data protection
Schema {πΊοΈ}
WebPage:
mainEntity:
headline:Cyclooxygenase (COX)-2 immunoreactivity and relationship to p53 and Ki-67 expression in colorectal cancer
description: The tumor-suppressive effects of nonsteroidal antiinflammatory drugs (NSAIDs) have been suggested to be due to a reduction in cyclooxygenase (COX)-2 activity, although the effects of COX-2 in the colonic mucosa and in colorectal cancer have not been determined. Ki-67 immunoreactivity in cancers is also attracting attention, as Ki-67 reflects cell proliferation, while p53 immunoreactivity is also of interest, as it reflects the malignancy of colorectal lesions. Accordingly, to determine these correlation, we investigated the distribution and intensity of COX-2, p53 and Ki-67 expression in both cancerous and non-cancerous tissues from patients with sporadic and ulcerative colitis (UC)-associated colorectal cancer. We selected 21 colorectal cancer specimens, obtained by surgical resection or colonoscopic biopsy, from 21 patients, including 3 with UC (13 men and 8 women; aged 42β78 years). Histological examination of hematoxylin and eosin-stained specimens revealed that 9 were well differentiated; 11, moderately differentiated; and 1 was a poorly differentiated adenocarcinoma. We used anti-COX-2, p53, and Ki-67 antisera to perform immunohistochemical staining by the labelled streptavidin biotin method and then assessed and graded the staining intensity and distribution. COX-2 staining was more intense in cancer tissue than in non-cancerous areas. Colorectal cancers associated with UC were not stained intensely. COX-2, p53, and Ki-67 positivity rates in were 38.1%, 38.1%, and 47.6%, respectively. There were no relationships among the distributions or intensities of COX-2, p53, and Ki-67 expression. Our results indicate that colorectal cancer tissues overexpress COX-2, but that there are no relationships between COX-2, p53, and Ki-67 expression, suggesting that COX-2 expression may not be related to cell proliferation or to the grade of malignancy. However, it is necessary to determine whether COX-2 in cancer tissue is involved in carcinogenesis or whether it is simply a product of cancer.
datePublished:
dateModified:
pageStart:189
pageEnd:194
sameAs:https://doi.org/10.1007/s005350050242
keywords:
Key words: COX-2
p53
Ki-67
colorectal cancer
Gastroenterology
Hepatology
Abdominal Surgery
Colorectal Surgery
Surgical Oncology
image:
isPartOf:
name:Journal of Gastroenterology
issn:
1435-5922
0944-1174
volumeNumber:34
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Kazuhiro Sakuma
affiliation:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan
address:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan, , JP
type:PostalAddress
type:Organization
type:Person
name:Takahiro Fujimori
affiliation:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan
address:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan, , JP
type:PostalAddress
type:Organization
type:Person
name:Kaoru Hirabayashi
affiliation:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan
address:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan, , JP
type:PostalAddress
type:Organization
type:Person
name:Akira Terano
affiliation:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan
address:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan, , JP
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Cyclooxygenase (COX)-2 immunoreactivity and relationship to p53 and Ki-67 expression in colorectal cancer
description: The tumor-suppressive effects of nonsteroidal antiinflammatory drugs (NSAIDs) have been suggested to be due to a reduction in cyclooxygenase (COX)-2 activity, although the effects of COX-2 in the colonic mucosa and in colorectal cancer have not been determined. Ki-67 immunoreactivity in cancers is also attracting attention, as Ki-67 reflects cell proliferation, while p53 immunoreactivity is also of interest, as it reflects the malignancy of colorectal lesions. Accordingly, to determine these correlation, we investigated the distribution and intensity of COX-2, p53 and Ki-67 expression in both cancerous and non-cancerous tissues from patients with sporadic and ulcerative colitis (UC)-associated colorectal cancer. We selected 21 colorectal cancer specimens, obtained by surgical resection or colonoscopic biopsy, from 21 patients, including 3 with UC (13 men and 8 women; aged 42β78 years). Histological examination of hematoxylin and eosin-stained specimens revealed that 9 were well differentiated; 11, moderately differentiated; and 1 was a poorly differentiated adenocarcinoma. We used anti-COX-2, p53, and Ki-67 antisera to perform immunohistochemical staining by the labelled streptavidin biotin method and then assessed and graded the staining intensity and distribution. COX-2 staining was more intense in cancer tissue than in non-cancerous areas. Colorectal cancers associated with UC were not stained intensely. COX-2, p53, and Ki-67 positivity rates in were 38.1%, 38.1%, and 47.6%, respectively. There were no relationships among the distributions or intensities of COX-2, p53, and Ki-67 expression. Our results indicate that colorectal cancer tissues overexpress COX-2, but that there are no relationships between COX-2, p53, and Ki-67 expression, suggesting that COX-2 expression may not be related to cell proliferation or to the grade of malignancy. However, it is necessary to determine whether COX-2 in cancer tissue is involved in carcinogenesis or whether it is simply a product of cancer.
datePublished:
dateModified:
pageStart:189
pageEnd:194
sameAs:https://doi.org/10.1007/s005350050242
keywords:
Key words: COX-2
p53
Ki-67
colorectal cancer
Gastroenterology
Hepatology
Abdominal Surgery
Colorectal Surgery
Surgical Oncology
image:
isPartOf:
name:Journal of Gastroenterology
issn:
1435-5922
0944-1174
volumeNumber:34
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Kazuhiro Sakuma
affiliation:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan
address:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan, , JP
type:PostalAddress
type:Organization
type:Person
name:Takahiro Fujimori
affiliation:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan
address:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan, , JP
type:PostalAddress
type:Organization
type:Person
name:Kaoru Hirabayashi
affiliation:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan
address:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan, , JP
type:PostalAddress
type:Organization
type:Person
name:Akira Terano
affiliation:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan
address:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan, , JP
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Journal of Gastroenterology
issn:
1435-5922
0944-1174
volumeNumber:34
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan
address:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan, , JP
type:PostalAddress
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan
address:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan, , JP
type:PostalAddress
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan
address:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan, , JP
type:PostalAddress
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan
address:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan, , JP
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Kazuhiro Sakuma
affiliation:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan
address:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan, , JP
type:PostalAddress
type:Organization
name:Takahiro Fujimori
affiliation:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan
address:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan, , JP
type:PostalAddress
type:Organization
name:Kaoru Hirabayashi
affiliation:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan
address:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan, , JP
type:PostalAddress
type:Organization
name:Akira Terano
affiliation:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan
address:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan, , JP
type:PostalAddress
type:Organization
PostalAddress:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan, , JP
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan, , JP
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan, , JP
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan, , JP
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {π}(31)
- Explore the financials of https://www.springernature.com/gp/authors
- What's the monthly money flow for https://link.springernature.com/home/?
- https://order.springer.com/public/cart's financial summary
- Revenue of https://www.editorialmanager.com/joga
- How much does https://www.springernature.com/gp/librarians/licensing/agc/journals gross monthly?
- Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kazuhiro%20Sakuma
- Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kazuhiro%20Sakuma%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Takahiro%20Fujimori pull in?
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Takahiro%20Fujimori%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kaoru%20Hirabayashi?
- Discover the revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kaoru%20Hirabayashi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Akira%20Terano
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Akira%20Terano%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- How much does https://s100.copyright.com/AppDispatchServlet?title=Cyclooxygenase%20%28COX%29-2%20immunoreactivity%20and%20relationship%20to%20p53%20and%20Ki-67%20expression%20in%20colorectal%20cancer&author=Kazuhiro%20Sakuma%20et%20al&contentID=10.1007%2Fs005350050242©right=Springer-Verlag%20Tokyo&publication=0944-1174&publicationDate=1999-03&publisherName=SpringerNature&orderBeanReset=true rake in every month?
- https://citation-needed.springer.com/v2/references/10.1007/s005350050242?format=refman&flavour=citation's total income per month
- What's the financial gain of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral?
- How much does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research make?
- Monthly income for https://www.springernature.com/gp/products
- What's the monthly money flow for https://www.springernature.com/gp/librarians?
- How much cash flow does https://www.springernature.com/gp/societies have monthly?
- What's the financial gain of https://www.springernature.com/gp/partners?
- What is the monthly revenue of https://www.springer.com/?
- Monthly income for https://www.nature.com/
- https://www.biomedcentral.com/'s total income per month
- How much does https://www.palgrave.com/ pull in?
- Find out how much https://www.apress.com/ earns monthly
- What is the monthly revenue of https://www.springernature.com/gp/legal/ccpa?
- What's the financial intake of https://www.springernature.com/gp/info/accessibility?
- How much does https://support.springernature.com/en/support/home rake in every month?
- How much revenue does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations produce monthly?
- How much does https://www.springernature.com/ gross monthly?
Analytics and Tracking {π}
- Google Tag Manager
Libraries {π}
- Clipboard.js
- Prism.js
CDN Services {π¦}
- Crossref